Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogenic Bone Marrow Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00001144
What this trial is testing

Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myeloid LeukemiaGraft vs Host Disease
National Heart, Lung, and Blood Institute (NHLBI) 50
Testing effectiveness (Phase 2)Study completedNCT02333058
What this trial is testing

Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies

Who this might be right for
Acute Lymphoblastic Leukaemias (ALL)Acute Myeloid Leukaemias (AML)Myelodysplastic Syndromes (MDS)+1 more
medac GmbH 70
Early research (Phase 1)Looking for participantsNCT06287944
What this trial is testing

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT00002552
What this trial is testing

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 40
Testing effectiveness (Phase 2)Looking for participantsNCT07493538
What this trial is testing

MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases

Who this might be right for
AMLMDSAcute Leukemia+2 more
Masonic Cancer Center, University of Minnesota 132
Not applicableWithdrawnNCT00898612
What this trial is testing

Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Lymphoma
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT00321932
What this trial is testing

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+2 more
University of Minnesota 61
Large-scale testing (Phase 3)Study completedNCT00209352
What this trial is testing

Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant

Who this might be right for
VZV Infection After Bone Marrow Transplantation
Fred Hutchinson Cancer Center 120
Early research (Phase 1)UnknownNCT04709458
What this trial is testing

Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis

Who this might be right for
MyelofibrosisAcute Myelogenous Leukemia
Taiga Biotechnologies, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT00003961
What this trial is testing

Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00002831
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT01772953
What this trial is testing

Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Center for International Blood and Marrow Transplant Research 40
Large-scale testing (Phase 3)Study completedNCT02942173
What this trial is testing

CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 150
Testing effectiveness (Phase 2)UnknownNCT01221454
What this trial is testing

Allogenic Bone Marrow Stem Cell Transplantation in Liver Failure

Who this might be right for
Liver Failure
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Study completedNCT00003838
What this trial is testing

Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

Who this might be right for
Myeloproliferative DisordersAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 202
Not applicableStudy completedNCT01095874
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional Study

Who this might be right for
Myelodysplasia
Saint-Louis Hospital, Paris, France 164
Early research (Phase 1)Looking for participantsNCT05473910
What this trial is testing

T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
AMLMDS
TScan Therapeutics, Inc. 310
Testing effectiveness (Phase 2)Study completedNCT00326417
What this trial is testing

Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)

Who this might be right for
Anemia, Aplastic
Medical College of Wisconsin 97
Large-scale testing (Phase 3)UnknownNCT00966810
What this trial is testing

Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion

Who this might be right for
Philadelphia Chromosome-positive Chronic Myelocytic Leukemia
Rambam Health Care Campus 40
Testing effectiveness (Phase 2)UnknownNCT01451268
What this trial is testing

Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia
Johann Wolfgang Goethe University Hospital 62
Next Page